Breyanzi (lisocabtagene maraleucel) - BMS
Liso-cel delivers: is the debate over for 3L FL? (PubMed, Blood) - Oct 2, 2026 - No abstract available 
Journal
http://www.ncbi.nlm.nih.gov/pubmed/42821304
 
Caron A Jacobson; Karina N Ruiz-Esteves
 
Oct 2, 2026
 
Prev Next